[ICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease]

Z Gastroenterol. 1999 Apr;37(4):313-5.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Crohn Disease / genetics
  • Crohn Disease / therapy*
  • Double-Blind Method
  • Female
  • Gene Expression / drug effects
  • Humans
  • Intercellular Adhesion Molecule-1 / genetics*
  • Male
  • Middle Aged
  • Oligonucleotides, Antisense / therapeutic use*

Substances

  • Oligonucleotides, Antisense
  • Intercellular Adhesion Molecule-1